Pharmaceuticals: French pharmaceutical giant Sanofi enters German Cheplapharm
Sanofi and Cheplapharm have been working together since 2014. Now the French are taking a stake in the German company. For the first time, Cheplapharm will also be manufacturing drugs itself in the future.
Sanofi is taking a 26.4% stake in Cheplapharm, a German pharmaceutical company, in exchange for 20 of its medication brands, including Lovenox. Cheplapharm will also acquire three production facilities in Hungary, Singapore, and France, with a total of 565 employees. The company currently employs 800 people and has previously outsourced its medication production.
Cheplapharm and Sanofi have been collaborating since 2014, but this marks the first time they have had a stake in each other. Last year, Cheplapharm reported a revenue of 1.66 billion euros and an operating profit of 643 million euros.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
